Natus Medical (NASDAQ:NTUS – Get Score) was downgraded by study analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a investigate notice issued on Saturday.
Natus Medical inventory opened at $32.70 on Friday. The company’s fifty day easy relocating regular is $32.63 and its 200-working day simple going ordinary is $27.65. Natus Medical has a 12 thirty day period minimal of $20.90 and a 12 thirty day period substantial of $33.93. The stock has a current market cap of $1.13 billion, a P/E ratio of 88.38 and a beta of .23.
Natus Medical (NASDAQ:NTUS – Get Ranking) previous issued its quarterly earnings information on Thursday, Might 5th. The enterprise described $.22 earnings per share (EPS) for the quarter, lacking analysts’ consensus estimates of $.26 by ($.04). The business had earnings of $119.79 million during the quarter, in comparison to the consensus estimate of $119.80 million. Natus Medical experienced a return on fairness of 10.15% and a internet margin of 2.65%. All through the identical quarter in the prior calendar year, the corporation posted $.16 earnings for each share. On normal, exploration analysts foresee that Natus Medical will put up 1.44 earnings for each share for the existing 12 months.
Big investors have not long ago modified their holdings of the stock. UMB Financial institution N A MO purchased a new stake in Natus Medical in the fourth quarter worth $29,000. To start with Horizon Advisors Inc. boosted its holdings in Natus Medical by 1,529.9% in the fourth quarter. First Horizon Advisors Inc. now owns 1,581 shares of the company’s inventory truly worth $37,000 just after paying for an supplemental 1,484 shares in the final quarter. Captrust Fiscal Advisors boosted its holdings in Natus Medical by 138.3% in the 1st quarter. Captrust Financial Advisors now owns 1,823 shares of the company’s inventory well worth $48,000 just after paying for an more 1,058 shares in the very last quarter. Pinebridge Investments L.P. acquired a new stake in Natus Medical during the fourth quarter valued at about $50,000. Ultimately, Prospera Fiscal Products and services Inc bought a new stake in Natus Medical all through the 1st quarter valued at about $60,000. Hedge money and other institutional buyers own 92.35% of the company’s stock.
About Natus Medical (Get Score)
Natus Medical Incorporated supplies medical device methods focuses on the diagnosis and treatment of clients with central nervous and sensory system issues all over the world. It provides solutions and technologies applied for the screening, detection, treatment, checking, and monitoring of typical medical ailments in new child care, listening to impairment, neurological and neurosurgical treatment plans, epilepsy, sleep diseases, and neuromuscular health conditions.
Showcased Tales
Receive Information & Ratings for Natus Medical Every day – Enter your electronic mail address under to obtain a concise each day summary of the most current information and analysts’ ratings for Natus Medical and relevant businesses with MarketBeat.com’s Free each day e-mail e-newsletter.
